View More Recent Stories

Jul 1, 2015 01:07AM TAUBE HODSON STONEX PARTNERS LLP ANNOUNCE 5.14% SHAREHOLDING IN ABLYNX
Jun 30, 2015 02:07AM ABLYNX AND TAISHO SIGN EXCLUSIVE LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTI-TNFa NANOBODY (OZORALIZUMAB) IN JAPAN
May 13, 2015 01:09AM ABLYNX ANNOUNCES BUSINESS UPDATE AND FINANCIAL RESULTS FOR THE FIRST THREE MONTHS OF 2015
Apr 15, 2015 01:08AM FMR LLC PROVIDE NOTIFICATION OF SHAREHOLDING IN ABLYNX
Apr 7, 2015 12:07PM ABLYNX ANNOUNCES PUBLICATION OF 2014 ANNUAL REPORT AND LAUNCH OF NEW WEBSITE
Apr 7, 2015 01:05AM ABLYNX INITIATES THE SECOND OF TWO PHASE IIb RA STUDIES WITH ITS ANTI-IL-6R NANOBODY, PARTNERED WITH ABBVIE
Mar 26, 2015 02:09AM ABLYNX ANNOUNCES EXTENSION OF ION CHANNEL RESEARCH COLLABORATION WITH MERCK & CO., INC.
Mar 17, 2015 02:08AM ABLYNX INITIATES THE FIRST OF TWO PHASE IIb RA STUDIES WITH ITS ANTI-IL-6R NANOBODY, PARTNERED WITH ABBVIE
Mar 16, 2015 01:13PM ABLYNX ANNOUNCES WARRANT EXERCISE
Mar 16, 2015 02:03AM POLAR CAPITAL FUNDS PLC AND FMR LLC PROVIDE NOTIFICATION OF SHAREHOLDING IN ABLYNX
View More Recent Stories